🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patient selection: a) Pathological confirmation of non-small cell lung canc...
Status
Terminated
Location
Geisel School of Medicine at Dartmouth
Start Date
2016-12-07
Trial ID
NCT02991651
Study Rationale: There is increasing evidence that erlotinib improves over...
Status
Completed
Location
Meir Medical Center
Start Date
2009-02
Trial ID
NCT00840125
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
The purpose of this study is to determine whether erlotinib plus pemetrexed...
Status
Completed
Location
The first affiliated hospital of Guangzhou MC
Start Date
2012-01
Trial ID
NCT01578668
Treatments Being Tested
1. Title and stage of study A Phase II Study to Assess Efficacy of Combined...
Status
Unknown
Location
Gosin University Gospel Hospital
Start Date
2014-04
Trial ID
NCT02146118
Treatments Being Tested
This multicenter, observational study will evaluate the efficacy and safety...
Status
Completed
Location
Clinical Center of Serbia; Institute For Pulmology
Start Date
2013-05
Trial ID
NCT01836133
Treatments Being Tested
This 2 arms study will compare the efficacy and safety of treatment with se...
Status
Completed
Location
Service de Pneumologie, CHU Angers
Start Date
2011-06
Trial ID
NCT01350817
Treatments Being Tested
Both pemetrexed and erlotinib are second-line treatment options for patient...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2008-12
Trial ID
NCT01565538
Treatments Being Tested
This Phase II, multicenter, randomized trial is designed to make preliminar...
Status
Completed
Location
Comprehensive Blood and Cancer Center (TORI)
Start Date
2004-07
Trial ID
NCT00095225
Treatments Being Tested